CPHI AMEX
China Pharma Holdings, Inc.
1W: -14.7%
1M: -24.1%
3M: -6.1%
YTD: -47.0%
1Y: -67.0%
3Y: -90.8%
5Y: -99.8%
$0.66
+0.00 (+0.61%)
Weekly Expected Move ±8.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$15M
-9.6% ▼
5Y CAGR: -7.7%
Total Liabilities
$7M
-20.8% ▼
5Y CAGR: -11.3%
Shareholders Equity
$8M
+3.9% ▲
5Y CAGR: -3.5%
Cash & Investments
$627K
-56.0% ▼
5Y CAGR: -10.2%
Total Debt
$4M
-22.5% ▼
5Y CAGR: -11.5%
Net Debt
$3M
-7.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $958K | $5M | $2M | $1M | $627K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $958K | $5M | $2M | $1M | $627K |
| Net Receivables | $530K | $835K | $464K | $728K | $281K |
| Inventory | $4M | $3M | $3M | $4M | $2M |
| Other Current Assets | $56K | $471 | $445K | $0 | $0 |
| Total Current Assets | $5M | $9M | $6M | $6M | $3M |
| Property, Plant & Equip. | $15M | $13M | $10M | $7M | $5M |
| Goodwill & Intangibles | $614K | $590K | $2M | $4M | $7M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $16M | $14M | $12M | $10M | $12M |
| Total Assets | $21M | $23M | $18M | $16M | $15M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $927K | $667K | $966K | $225K |
| Short-Term Debt | $6M | $7M | $9M | $3M | $2M |
| Deferred Revenue | $720K | $210K | $520K | $91K | $162K |
| Other Current Liabilities | $297K | $327K | $373K | $1M | $2M |
| Total Current Liabilities | $11M | $11M | $13M | $7M | $5M |
| Long-Term Debt | $904K | $5M | $0 | $1M | $1M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $2M | $6M | $755K | $2M | $2M |
| Total Liabilities | $13M | $17M | $13M | $9M | $7M |
| — Equity — | |||||
| Common Stock | $46K | $47K | $75K | $11K | $33K |
| Retained Earnings | -$29M | -$32M | -$36M | -$39M | -$44M |
| Accumulated OCI | $12M | $13M | $12M | $11M | $11M |
| Total Stockholders Equity | $8M | $6M | $4M | $7M | $8M |
| Total Liabilities & Equity | $21M | $23M | $18M | $16M | $15M |
| — Key Metrics — | |||||
| Total Debt | $7M | $12M | $9M | $5M | $4M |
| Net Debt | $6M | $8M | $7M | $3M | $3M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |